A bipartisan House committee has revealed that American pharmaceutical companies carried out drug trials in conjunction with the Chinese military for more than 10 years.
The revelation came in a letter penned by Republican and Democratic leaders on the House Select Committee on the Chinese Communist Party (CCP) to the commissioner of the Food and Drug Administration (FDA), Robert Califf. In the letter, they pressed him to supply information about these clinical trials for new medications.
In their letter, they explained: “These collaborative research activities raise serious concerns that critical Intellectual Property is at risk of being transferred to the [Chinese military] or being co-opted under the People’s Republic of China’s National Security Law.”
They also expressed reservations about how much the results of clinical trials produced by China can be trusted.
The letter states that hundreds of clinical trials for drugs have been carried out at medical centers and hospitals in China that are affiliated with the People’s Liberation Army (PLA) at sites such as the PLA’s Air Force Medical University and the PLA’s General Hospital and Medical School.
One of the institutions is operated by the PLA’s Academy of Military Medical Sciences, an institution which the Department of Commerce has banned businesses in the United States from sharing technology with due to national security concerns.
Hellbound and Down 